Examination of the effect of implantable cardioverter-defibrillators on health-related quality of life: Based on results from the multicenter automatic defibrillator trial-ii

American Journal of Cardiovascular Drugs

Volumn 9, Issue 6, 2009, Pages 393-400

  Noyes, Katia ^a   Corona, Ethan ^a   Veazie, Peter ^a   Dick, Andrew W ^b   Zhao, Hongwei ^a   Moss, Arthur J ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b RAND CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CLINICAL OBSERVATION; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DEFIBRILLATOR; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; SHOCK; THERAPY EFFECT; TREATMENT RESPONSE;

AGE FACTORS; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEALTH STATUS INDICATORS; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; RISK FACTORS; SEX FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 71149107430     PISSN: 11753277     EISSN: 1179187X     Source Type: Journal    
DOI: 10.2165/11317980-000000000-00000     Document Type: Article

References (21)

1. Agency for Healthcare Research and Quality. HCUPnet [online]. Available from URL: http://hcupnet.ahrq.gov/ [Accessed 2009 Sep 22]
2. Noyes K, Corona E, Zwanziger J, et al. Quality of life and economic consequences of implantable cardiac defibrillator: Results from MADIT II. Medical Care 2007; 45 (5): 377-385
3. MossAJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346 (12): 877-883
4. Leplege A, Hunt S. The problem of quality of life in medicine.JAMA1997; 278: 47-50
5. Testa MA, Simonson DC. Assesment of quality-of-life outcomes. N Engl J Med 1996 Mar 28; 334 (13): 835-840
6. Gold MR, Siegel J, Russell L, et al. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996
7. Sola CL, Bostwick JM. Implantable cardioverter-defibrillators induced anxiety, and quality of life. Mayo Clin Proc 2005; 80 (2): 232-237
8. Dunbar SB, Warner CD, Purcell JA. Internal cardioverter defibrillator device discharge: Experiences of patients and family members. Heart Lung 1993; 22 (6): 494-501
9. Sears SE, Conti JB. Understanding implantable cardioverter defibrillator shocks and storms: medical and psychosocial considerations for research and clinical care. Clin Cardiol 2003; 26 (3): 107-111
10. Carroll DL, Hamilton GA. Quality of life in implanted cardioverter defibrillator recipients: The impact of a device shock. Heart Lung 2005; 34 (3): 169-178
11. Wallace RL, Sears SF, Lewis TS, et al. Predictors of quality of life in long-term recipients of implantable cardioverter defibrillators. J Cardiopulm Rehabil 2002; 22: 278-281
12. Goldenberg I, Moss AJ, Hall WJ, et al. Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the Multicenter Automatic Defibrillator Implantation Trial II. Circulation 2006; 113: 2810-2817
13. Bryant J, BrodinH, Loveman E, et al. Clinical effectiveness and cost-effectiveness of implantable cardioverter defibrillators for arrhythmias: A systematic review and economic evaluation. Int J Technol Assess Health Care 2007; 23 (1): 63-70 (Pubitemid 46648301)
14. Zwanziger J, Hall WJ, Dick AW, et al. The cost effectiveness of implantable cardioverter-defibrillators: Results from theMulticenter Automatic Defibrillator Implantation Trial (MADIT)-II. J Am Coll Cardiol 2006; 47 (11): 2310-2318
15. Daubert JP, Zareba W, Hall WJ, et al. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. J Am Coll Cardiol 2006; 47 (1): 98-107
16. Furlong WJ, Feeny DH, Torrance GW, et al. The health utilities index (HUI) system for assessing health-related quality of life in clinical studies. Ann Med 2001 Jul; 33 (5): 375-384
17. Noyes K, Dick AW, Holloway RG. Dynamic changes in cost-effectiveness: Comparing pramipexole and levodopa in early Parkinson's disease. Pharmacoeconomics 2005; 23 (12): 1257-1270
18. Engels JMPD. Imputation of missing longitudinal data: A comparison of methods. J Clin Epi 2003; 56: 968-976
19. Kahneman D. Determinants of health economic decisions in actual practice: The role of behavioral economics. Value Health 2006; 9: 65-7
20. de Lissovoy G. The implantable cardiac defibrillator: Is the glass half empty or half full? Med Care 2007; 45 (5): 371-373
21. MarkDB,Nelson CL, AnstromKJ, et al. Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: Results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Circulation 2006; 114: 135-142